Dr. Ayesha Jawed's Research: Depression in Postmenopausal Women
Her CPSP research synopsis was approved on 1 August 2025. This page explains the study plan in simple words. The results aren't published yet.
Last updated 19 November 2026
What is Dr. Ayesha Jawed researching?
She's studying how common depression is in postmenopausal women. The College of Physicians and Surgeons Pakistan (CPSP) Research Evaluation Unit approved her synopsis, "Depression in postmenopausal women", on 1 August 2025 (reference CPSP/REU/OBG-2024-174-13681).
The synopsis is the written plan for the study. It's an approved plan, and no results are published. We don't make any claim about what the study will find, and it doesn't test any treatment. She's an MBBS doctor and postgraduate trainee in Obstetrics and Gynaecology (CPSP).
Her study documents say it's self-funded, with no outside or commercial funding, no conflict of interest to declare and no cost to the women who take part.
Why study depression after menopause?
Depression is common after menopause, and a 2024 review of 50 studies found it in about 28 of every 100 postmenopausal women. Her study plan says mental health is an even more neglected part of care for these women in Pakistan.
Menopause means 12 months without a period. The World Health Organization (WHO) says most women reach it between 45 and 55. Her study plan gives about 49 as the average age in Pakistan, citing a 2022 study by Memon and colleagues.
The 2024 review, by Li and colleagues in BMC Psychiatry, included 385,092 women. It found 37.3% in developing countries and 15.9% in developed ones. The numbers aren't the same everywhere, because they change with the place and with how each study measured depression. That's why a local study matters.
Her plan also says many people in Pakistan don't seek mental healthcare because of stigma and low awareness. Knowing how many women are affected locally may help raise awareness about asking for help. Our guide to depression in postmenopausal women covers the signs and where to get help.
How is the study designed?
It's a cross-sectional study, which means it looks at a group of women at one point in time. It plans to include 121 postmenopausal women from the outpatient department of Obstetrics and Gynaecology at a hospital in Karachi, over 6 months after CPSP approval.
The women are picked by non-probability consecutive sampling, which means women who attend and meet the criteria are included one after another. They're not chosen by hand. The aim is stated in one sentence: to determine the frequency of depression in postmenopausal women.
Who can take part?
Women aged 55 or older who haven't had a period for more than 12 months can take part. Four groups aren't included:
- Women with a psychiatric disorder before menopause.
- Women who are taking, or have taken, antidepressant medicine.
- Women with a history of substance abuse.
- Women who drink alcohol.
The first three are checked from previous medical records.
How is depression measured?
Here's the tool. Depression is measured with the Hamilton Depression Rating Scale (HAM-D). A total score above 7 counts as depression. A score of 8 to 16 is mild, 17 to 23 is moderate and 24 or higher is severe.
Each woman fills in the scale alone in a separate room, and the researcher collects all the data herself to avoid bias.
How was the sample size worked out?
It was calculated with the Raosoft sample size calculator at 95% confidence and 8% absolute precision, expecting 28% of women to have depression. That gives 121 women. The 28% comes from the 2024 review above.
What happens to the women who take part?
Each woman is told about the study first, takes part by choice and gives written consent in English or Urdu. Her privacy is kept during the assessment, and her data doesn't leave the study.
The study documents also say a woman found to have depression gets appropriate care as advised by a psychiatrist.
The researcher also records age, body mass index (BMI), years since menopause, education, rural or urban home, marital status, number of pregnancies and whether she works. The data is analysed with SPSS software, version 20, using chi-square or Fisher's exact tests, and a p-value of 0.05 or less counts as significant.
What is the status of the study?
The synopsis is approved, and the results aren't published. Nothing on this page is a finding, and we won't add one until the results are published. Here's what we know today: the plan is approved.
We'll update this page when that happens. You can also read about Dr. Ayesha Jawed, or message her about menopause questions through the booking form.
Questions people ask
Is the study finished?
No. The synopsis was approved on 1 August 2025, and no results are published. We don't report any findings.
Is this advice for my own health?
No. This page describes a study plan. If you feel low, tired or hopeless for more than 2 weeks, talk to a doctor. In an emergency, go to the nearest hospital emergency now, or call Edhi on 115.
Sources
- BMC Psychiatry, via PubMed Central, Prevalence and associated factors of depression in postmenopausal women: a systematic review and meta-analysis (Li et al., 2024) (opens in a new tab), accessed 19 November 2026.
- World Health Organization, Menopause fact sheet (opens in a new tab), accessed 19 November 2026.